Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system

被引:56
作者
Yoshida, M [1 ]
Mahato, RI [1 ]
Kawabata, K [1 ]
Takakura, Y [1 ]
Hashida, M [1 ]
机构
[1] KYOTO UNIV,FAC PHARMACEUT SCI,DEPT DRUG DELIVERY RES,SAKYO KU,KYOTO 60601,JAPAN
关键词
plasmid DNA; liver perfusion; pharmacokinetics; gene therapy;
D O I
10.1023/A:1016058407671
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To define the hepatic uptake mechanism of a plasmid DNA, we quantitated the uptake of pCAT (plasmid DNA encoding chloramphenicol acetyltransferase reporter gene fused to simian virus 40 promoter), a model plasmid, after a single pass through the perfused rat liver using albumin- and erythrocyte-free Krebs-Ringer bicarbonate buffer (pH 7.4). Methods. [P-32]pCAT was introduced momentarily into this system from the portal vein as a bolus input or constant infusion mode, and the outflow patterns and hepatic uptake were evaluated using statistical moment analysis. Results. The venous outflow samples had electrophoretic bands similar to that of the standard pCAT, suggesting that the plasmid is fairly stable in the perfusate during liver perfusion. In bolus experiments, pCAT was largely taken up by the liver and the uptake was decreased with increase in injected dose. Statistical moment analysis against outflow patterns demonstrated that the apparent volume of distribution of pCAT was greater than that of human serum albumin, indicating a significant reversible interaction with the tissues. The results of collagenase perfusion experiments suggest that the hepatic accumulation of pCAT occurred preferentially in the nonparenchymal cells (NPC). The amount of total recovery in the liver decreased substantially by preceding administration of polyinosinic acid, dextran sulfate, succinylated bovine serum albumin, but not by polycytidylic acid. This suggests that pCAT is taken up by the liver via scavenger receptors for polyanions on the NPC. In constant infusion experiments, the presence of 2,4-dinitrophenol and NH4Cl caused a significant increase in the outflow concentration of [P-32]pCAT and decrease by half in the total hepatic recovery than that of plasmid DNA administered alone, suggesting that plasmid DNA may undergo internalization by the NPC. Conclusions. The liver plays an important role in the elimination of plasmid DNA and a successful delivery system will be required to avoid its recognition by the scavenger receptors on the liver NPC.
引用
收藏
页码:599 / 603
页数:5
相关论文
共 15 条
[1]  
ACTON S, 1993, J BIOL CHEM, V268, P3530
[2]   TYROSINE PHOSPHORYLATION OF THE INSULIN-RECEPTOR IS NOT REQUIRED FOR RECEPTOR INTERNALIZATION - STUDIES IN 2,4-DINITROPHENOL-TREATED CELLS [J].
BACKER, JM ;
KAHN, CR ;
WHITE, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3209-3213
[3]   UPTAKE AND DEGRADATION OF BOVINE TESTES BETA-GALACTOSIDASE BY PARENCHYMAL AND NONPARENCHYMAL RAT-LIVER CELLS [J].
BLOMHOFF, R ;
BLOMHOFF, HK ;
TOLLESHAUG, H ;
CHRISTENSEN, TB ;
BERG, T .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1985, 17 (12) :1321-1328
[4]   THE SCAVENGER CELL PATHWAY FOR LIPOPROTEIN DEGRADATION - SPECIFICITY OF THE BINDING-SITE THAT MEDIATES THE UPTAKE OF NEGATIVELY-CHARGED LDL BY MACROPHAGES [J].
BROWN, MS ;
BASU, SK ;
FALCK, JR ;
HO, YK ;
GOLDSTEIN, JL .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1980, 13 (01) :67-81
[5]  
EMLEN W, 1984, CLIN EXP IMMUNOL, V56, P185
[6]   A NEW METHOD FOR ASSESSMENT OF DRUG DISPOSITION IN MUSCLE - APPLICATION OF STATISTICAL MOMENT THEORY TO LOCAL PERFUSION SYSTEMS [J].
KAKUTANI, T ;
YAMAOKA, K ;
HASHIDA, M ;
SEZAKI, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1985, 13 (06) :609-631
[7]   THE FATE OF PLASMID DNA AFTER INTRAVENOUS-INJECTION IN MICE - INVOLVEMENT OF SCAVENGER RECEPTORS IN ITS HEPATIC-UPTAKE [J].
KAWABATA, K ;
TAKAKURA, Y ;
HASHIDA, M .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :825-830
[8]   IN-VIVO DISPOSITION CHARACTERISTICS OF PLASMID DNA COMPLEXED WITH CATIONIC LIPOSOMES [J].
MAHATO, RI ;
KAWABATA, K ;
TAKAKURA, Y ;
HASHIDA, M .
JOURNAL OF DRUG TARGETING, 1995, 3 (02) :149-157
[9]  
NAITO M, 1991, AM J PATHOL, V139, P1411
[10]  
NISHIDA K, 1990, INT J PHARM, V65, P7